Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.436 USD | +0.27% | -1.75% | -60.38% |
27/02 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
27/02 | Top Midday Decliners | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 17.04M 1.42B |
---|---|---|---|---|---|
Net income 2024 * | -32M -2.67B | Net income 2025 * | -54M -4.5B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.68
x | P/E ratio 2025 * |
-0.54
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Minerva Neurosciences, Inc.
1 day | +0.27% | ||
1 week | -1.75% | ||
Current month | -5.56% | ||
1 month | -5.19% | ||
3 months | -70.07% | ||
6 months | -45.98% | ||
Current year | -60.38% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 01/14/01 | |
Geoff Race
FOU | Founder | 63 | 01/10/01 |
Fred Ahlholm
DFI | Director of Finance/CFO | 58 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeryl Hilleman
BRD | Director/Board Member | 66 | 17/18/17 |
Jan van Heek
BRD | Director/Board Member | 75 | 01/14/01 |
Director/Board Member | 68 | 10/17/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.436 | +0.27% | 4,167 |
25/24/25 | 2.43 | -3.57% | 5,770 |
24/24/24 | 2.52 | -0.40% | 3,943 |
23/24/23 | 2.53 | -0.78% | 4,587 |
22/24/22 | 2.55 | +2.82% | 10,036 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.38% | 17.04M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NERV Stock